Persistent SARS-Cov-2 Infection in an Immunocompromised Host: Role of the Cellular Immune Response
We present a patient with B-cell depletion and persistence of positive SARS-CoV-2 RT-PCR along 19 weeks despite having received treatment with corticosteroids, Convalescent Plasma (CP) and remdesivir. Direct genome sequences were obtained with a pattern of substitutions characteristic of the B.1.1.7...
| Autores: | , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2023 |
| País: | Argentina |
| Recursos: | Consejo Nacional de Investigaciones Científicas y Técnicas |
| Repositorio: | CONICET Digital (CONICET) |
| Idioma: | inglés |
| OAI Identifier: | oai:ri.conicet.gov.ar:11336/225574 |
| Acesso em linha: | http://hdl.handle.net/11336/225574 |
| Access Level: | acceso abierto |
| Palavra-chave: | SARS COV-2 Variants Vaccine sequence COVID-19 https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
| Resumo: | We present a patient with B-cell depletion and persistence of positive SARS-CoV-2 RT-PCR along 19 weeks despite having received treatment with corticosteroids, Convalescent Plasma (CP) and remdesivir. Direct genome sequences were obtained with a pattern of substitutions characteristic of the B.1.1.7 (alpha) lineage and the presence of mutations during its viral persistence. Although specific humoral response was not detected, there was evidence of a specific cellular response that was enhanced after the first dose of the vaccine. |
|---|